Literature DB >> 10884612

Peripheral pathogenesis of prion diseases.

M Glatzel1, A Aguzzi.   

Abstract

Prions are infectious pathogens that cause a group of neurodegenerative diseases characterized by spongiform degeneration of the central nervous system. Prions appear to lack any informational nucleic acid. The most notable prion diseases include bovine spongiform encephalopathy, scrapie in sheep and Creutzfeldt-Jakob disease of humans. Transmission is thought to be achieved through conversion of a normal host protein into a pathological isoform. Although the main pathological changes during the course of the disease occur in the brain, the infectious agent accumulates early in lymphoid tissue. The subsequent development of clinical disease depends on the presence of an intact immune system including mature B-cells. In this article we review the state of knowledge on the routes of neuroinvasion used by the infectious agent in order to gain access to the central nervous system upon entry into extracerebral sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884612     DOI: 10.1016/s1286-4579(00)00364-6

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  10 in total

Review 1.  Prion diseases and the gastrointestinal tract.

Authors:  G A Davies; Adam R Bryant; John D Reynolds; Frank R Jirik; Keith A Sharkey
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

2.  Detection of chronic wasting disease prions in salivary, urinary, and intestinal tissues of deer: potential mechanisms of prion shedding and transmission.

Authors:  Nicholas J Haley; Candace K Mathiason; Scott Carver; Mark Zabel; Glenn C Telling; Edward A Hoover
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

3.  Detection of disease-associated prion protein in the optic nerve and the adrenal gland of cattle with bovine spongiform encephalopathy by using highly sensitive immunolabeling procedures.

Authors:  Hiroyuki Okada; Yoshifumi Iwamaru; Shigeo Fukuda; Takashi Yokoyama; Shirou Mohri
Journal:  J Histochem Cytochem       Date:  2012-01-19       Impact factor: 2.479

Review 4.  Prion disease modelled in Drosophila.

Authors:  Raymond Bujdoso; Andrew Smith; Oliver Fleck; John Spiropoulos; Olivier Andréoletti; Alana M Thackray
Journal:  Cell Tissue Res       Date:  2022-01-29       Impact factor: 5.249

Review 5.  The role of the prion protein membrane anchor in prion infection.

Authors:  Suzette A Priola; Kristin L McNally
Journal:  Prion       Date:  2009-07-07       Impact factor: 3.931

6.  Cultured peripheral neuroglial cells are highly permissive to sheep prion infection.

Authors:  Fabienne Archer; Corinne Bachelin; Olivier Andreoletti; Nathalie Besnard; Gregory Perrot; Christelle Langevin; Annick Le Dur; Didier Vilette; Anne Baron-Van Evercooren; Jean-Luc Vilotte; Hubert Laude
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Subclinical prion disease induced by oral inoculation.

Authors:  Alana M Thackray; Michael A Klein; Raymond Bujdoso
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  Cells release prions in association with exosomes.

Authors:  Benoit Fevrier; Didier Vilette; Fabienne Archer; Damarys Loew; Wolfgang Faigle; Michel Vidal; Hubert Laude; Graça Raposo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

9.  Tissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levels.

Authors:  Alberto Rábano; Jesús de Pedro-Cuesta; Kåre Mølbak; Ake Siden; Miguel Calero; Henning Laursen
Journal:  BMC Public Health       Date:  2005-01-24       Impact factor: 3.295

Review 10.  Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens.

Authors:  Kang Cai; Todd M Gierman; JoAnn Hotta; Christopher J Stenland; Douglas C Lee; Dominique Y Pifat; Steve R Petteway
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.